SASKATOON, Saskatchewan, April 22, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC.
(“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the ling on SE
DAR+ of its audited nancial statements together with associated MD&A for the year ended December 31,
2024. To review the Corporation’s 2024 audited financial statements and associated MD&A please
visit SEDAR+ at www.sedarplus.ca.
About PharmaCorp Rx Inc.
PharmaCorp currently operates three PharmaChoice bannered pharmacies in Canada and will
continue to acquire PharmaChoice Canada branded pharmacies as they come to market in
conjunction with its strategic alliance agreement with PharmaChoice Canada. The Corporation will
also acquire independently owned non-PharmaChoice Canada bannered pharmacies in Canada,
and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada
banner. PharmaCorp shares trade on the TSX Venture Exchange under the symbol: PCRX.
For further information, contact:
Mr. Alan Simpson
Suite #203, 303 Wellman Lane, Saskatoon, SK S7T 0J1
Tel: (306) 536-3771
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is dened in
the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy
of this release.